You are here

  • Home
  • Archive
  • Volume 30, Issue 10
  • Poly (ADP-ribose) polymerase (PARP) inhibitor regimens for ovarian cancer in phase III randomized controlled trials: a network meta-analysis

Article metrics

Article menu
Download PDFPDF
Original research
Poly (ADP-ribose) polymerase (PARP) inhibitor regimens for ovarian cancer in phase III randomized controlled trials: a network meta-analysis

 

Online download statistics by month:

Online download statistics by month: August 2020 to October 2024

AbstractFullPdf
Aug 20205712318
Sep 20205722115
Oct 20203921910
Nov 20203541414
Dec 2020326105
Jan 2021283123
Feb 202115822
Mar 202116012
Apr 202124195
May 20215622
Jun 2021635
Jul 20211454
Aug 2021774
Sep 20211231
Oct 202111410
Nov 202129565
Dec 20217111
Jan 202214680
Feb 20227954
Mar 202226412
Apr 202219241
May 202213023
Jun 2022139105
Jul 202214042
Aug 20229930
Sep 202216270
Oct 202216071
Nov 202210642
Dec 202210411
Jan 202310532
Feb 202320620
Mar 202310622
Apr 20237286
May 20236200
Jun 20236921
Jul 20237120
Aug 20239972
Sep 20237320
Oct 20239433
Nov 202311433
Dec 20239333
Jan 202415511
Feb 20249411
Mar 20246454
Apr 202410811
May 202411566
Jun 202412344
Jul 20244474
Aug 20245931
Sep 202414931
Oct 20244000
Total7468263162